Literature DB >> 19296597

N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.

Päivi H Kiviranta1, Tiina Suuronen, Erik A A Wallén, Jukka Leppänen, Jussi Tervonen, Sergiy Kyrylenko, Antero Salminen, Antti Poso, Elina M Jarho.   

Abstract

N()-Thioacetyl-lysine-containing tri-, tetra-, and pentapeptides, based on the alpha-tubulin and p53 protein sequences, were studied as SIRT1 and SIRT2 inhibitors. The potency of the pentapeptides depended on the selection of the side chains. The removal of N- and C-terminal residues of the pentapeptides yielded tripeptides with retained SIRT1 inhibitory activity but decreased SIRT2 inhibitory activity. The most potent SIRT1 inhibitors were equipotent with the reference compound (6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide) with the IC(50) values of 180-330 nM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296597     DOI: 10.1021/jm801401k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Dual Genetic Encoding of Acetyl-lysine and Non-deacetylatable Thioacetyl-lysine Mediated by Flexizyme.

Authors:  Hai Xiong; Noah M Reynolds; Chenguang Fan; Markus Englert; Denton Hoyer; Scott J Miller; Dieter Söll
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-23       Impact factor: 15.336

2.  Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors.

Authors:  Piia Kokkonen; Minna Rahnasto-Rilla; Päivi H Kiviranta; Tero Huhtiniemi; Tuomo Laitinen; Antti Poso; Elina Jarho; Maija Lahtela-Kakkonen
Journal:  ACS Med Chem Lett       Date:  2012-10-23       Impact factor: 4.345

Review 3.  Sirtuin activators and inhibitors: Promises, achievements, and challenges.

Authors:  Han Dai; David A Sinclair; James L Ellis; Clemens Steegborn
Journal:  Pharmacol Ther       Date:  2018-03-22       Impact factor: 12.310

Review 4.  Sirtuin inhibitors as anticancer agents.

Authors:  Jing Hu; Hui Jing; Hening Lin
Journal:  Future Med Chem       Date:  2014-05       Impact factor: 3.808

5.  Side-chain thioamides as fluorescence quenching probes.

Authors:  D Miklos Robkis; Eileen M Hoang; Pengse Po; Carol J Deutsch; E James Petersson
Journal:  Biopolymers       Date:  2020-06-17       Impact factor: 2.505

6.  [Dual genetic encoding of acetyl-lysine and non-deacetylatablethioacetyl-lysine mediated by flexizyme].

Authors:  Hai Xiong; Noah M Reynolds; Chenguang Fan; Markus Englert; Denton Hoyer; Scott J Miller; Dieter Söll
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2016-02-23

Review 7.  Rejuvenating sirtuins: the rise of a new family of cancer drug targets.

Authors:  Santina Bruzzone; Marco Daniele Parenti; Alessia Grozio; Alberto Ballestrero; Inga Bauer; Alberto Del Rio; Alessio Nencioni
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.

Authors:  Maria Fridén-Saxin; Tina Seifert; Marie Rydén Landergren; Tiina Suuronen; Maija Lahtela-Kakkonen; Elina M Jarho; Kristina Luthman
Journal:  J Med Chem       Date:  2012-08-07       Impact factor: 7.446

9.  BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses.

Authors:  Tarja Kokkola; Tiina Suuronen; Maija Pesonen; Panagis Filippakopoulos; Antero Salminen; Elina M Jarho; Maija Lahtela-Kakkonen
Journal:  Chembiochem       Date:  2015-08-13       Impact factor: 3.164

Review 10.  Sirtuin functions and modulation: from chemistry to the clinic.

Authors:  Vincenzo Carafa; Dante Rotili; Mariantonietta Forgione; Francesca Cuomo; Enrica Serretiello; Gebremedhin Solomon Hailu; Elina Jarho; Maija Lahtela-Kakkonen; Antonello Mai; Lucia Altucci
Journal:  Clin Epigenetics       Date:  2016-05-25       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.